Drug Development Linked More Closely to Diagnostics

Published on: 
Pharmaceutical Technology, Pharmaceutical Technology-10-02-2004, Volume 28, Issue 10

FDA and industry discuss proposals for regulating combination diagnostics, medical devices, and pharmacogenomic-based drug products.

Related Content:

FormulationProcess ValidationQuality SystemsRegulatory WatchDevelopmentPharmaceutical Technology-10-02-2004
BioNTech and OncoC4 to Co-Develop mAb for Solid Tumor Indications
Never Mind the Statistics; Just Tell Me What the Answer Is!
Polyplus Introduces Novel LNP Formulation for Use in mRNA Therapeutics